Note 10 – Segment Reporting

 

Due to the new digital asset treasury strategy, the Company now has two reportable segments: digital asset treasury and clinical stage bio-technology.

 

The Company’s Chief Executive Officer serves as the Chief Operating Decision Maker (“CODM”) and evaluates the financial performance of the business and makes resource allocation decisions on the basis of net income/(loss) before income taxes.

 

Summary segment financial performance measures evaluated by the CODM as of December 31, 2025 and 2024 and for the years then ended is as follows:

 

       
   Segment Assets at December 31, 
   2025   2024 
Digital asset treasury segment  $513,964,900   $- 
Clinical stage bio-technology segment   5,181,535    3,721,624 
Total assets  $519,146,435   $3,721,624 

 

Digital asset treasury segment

 

       
   For the years ended December 31, 
   2025   2024 
Loss from operations  $(2,765,292)  $- 
Other income (expense) (a)   24,117    - 
Unrealized loss on digital assets holdings   (22,010,362)   - 
Total loss before income taxes  $(24,751,537)  $- 

 

Clinical stage bio-technology segment

 

       
   For the years ended December 31, 
   2025   2024 
Loss from operations  $(17,340,774)  $(12,433,792)
Other income (expense) (a)   (11,052)   236,224 
Total loss before income taxes  $(17,351,826)  $(12,197,568)

 

(a)Other income (expense) consists of interest income and interest expense.

 

The following table is a reconciliation of segment total loss before income taxes to our consolidated total loss before income taxes.

 

         
   For the years ended December 31, 
   2025   2024 
Digital asset treasury segment total loss before income taxes  $(24,751,537)  $- 
Clinical stage bio-technology segment total loss before income taxes   (17,351,826)   (12,197,568)
Consolidated total loss before income taxes  $(42,103,363)  $(12,197,568)

 

 

Free Sentinel

Want the next Canton Strategic Holdings, Inc. segments disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment Canton Strategic Holdings, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.